Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SHOULDER INNOVATIONS, INC. (SI) Financial Statements

SHOULDER INNOVATIONS, INC. (SI) reported trailing twelve-month revenue of $60.1M (up 60.9% year on year) and net income of -$35.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$47.1M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SISHOULDER INNOVATIONS, INC.Follow SI — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
409.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue31.647.360.1
Gross profit24.336.246.4
Research & development4.57.711.9
Operating income-14.7-26.3-35.2
Pre-tax income-15.6-40.4-35.0
Income tax0.00.00.0
Net income-15.6-40.4-35.0
Diluted EPS ($)-242.04-4.65-1.69
Diluted shares (mn)0.18.7—

USD millions · SEC XBRL

SHOULDER INNOVATIONS, INC. — questions

What is SHOULDER INNOVATIONS, INC.'s revenue?
$60.1M over the twelve months to 2026-06-30, up 60.9% year on year, from its 10-Q and 10-K filings.
What is SHOULDER INNOVATIONS, INC.'s net income?
-$35.0M over the twelve months to 2026-06-30.
What is SHOULDER INNOVATIONS, INC.'s free cash flow?
-$47.1M over the twelve months to 2026-06-30.
What are SHOULDER INNOVATIONS, INC.'s diluted earnings per share?
$-1.69 over the twelve months to 2026-06-30.

Every figure on this page comes from SHOULDER INNOVATIONS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.